- Home
- EQX vs PEN Comparison
EQX vs PEN Comparison
Compare EQX & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQX
- PEN
- Stock Information
- Founded
- EQX 2007
- PEN 2004
- Country
- EQX Canada
- PEN United States
- Employees
- EQX N/A
- PEN N/A
- Industry
- EQX Precious Metals
- PEN Medical/Dental Instruments
- Sector
- EQX Basic Materials
- PEN Health Care
- Exchange
- EQX Nasdaq
- PEN Nasdaq
- Market Cap
- EQX 8.4B
- PEN 9.7B
- IPO Year
- EQX N/A
- PEN 2015
- Fundamental
- Price
- EQX $10.97
- PEN $227.37
- Analyst Decision
- EQX Buy
- PEN Strong Buy
- Analyst Count
- EQX 1
- PEN 16
- Target Price
- EQX $17.00
- PEN $307.50
- AVG Volume (30 Days)
- EQX 13.9M
- PEN 360.3K
- Earning Date
- EQX 11-05-2025
- PEN 11-05-2025
- Dividend Yield
- EQX N/A
- PEN N/A
- EPS Growth
- EQX N/A
- PEN 916.05
- EPS
- EQX N/A
- PEN 3.74
- Revenue
- EQX $1,905,732,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- EQX $65.90
- PEN $15.52
- Revenue Next Year
- EQX $49.28
- PEN $14.20
- P/E Ratio
- EQX N/A
- PEN $60.82
- Revenue Growth
- EQX 74.31
- PEN 12.92
- 52 Week Low
- EQX $4.95
- PEN $207.58
- 52 Week High
- EQX $12.93
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- EQX 49.56
- PEN 27.69
- Support Level
- EQX $10.24
- PEN $228.72
- Resistance Level
- EQX $11.31
- PEN $260.00
- Average True Range (ATR)
- EQX 0.44
- PEN 7.65
- MACD
- EQX -0.19
- PEN -2.58
- Stochastic Oscillator
- EQX 27.14
- PEN 5.53
About EQX Equinox Gold Corp.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.